Clinical Trial Methods for Assessing a Tobacco Product
This is a multi-center trial involving University of Minnesota, Ohio State University and Roswell Park Cancer Center. Subjects who are eligible will enter a product (e-cigarette, nicotine gum, or nicotine lozenge) sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a baseline assessment phase and will then be randomized in the clinical trial phase to one of the three experimental conditions for eight weeks.
Study Number: 

I 222712

Methodological Study
Principal Investigator: 
ClinicalTrials.Gov ID: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail